Skip to content
777 Sourcing.

Capability

drug innovation using TransCon technology platform

Suppliers
1
States & provinces
1
Countries
1

1 drug innovation using transcon technology platform supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

Ascendis Pharma is a global biopharmaceutical company founded in 2007 and headquartered in Copenhagen, Denmark, with research facilities in Germany and offices across Europe and the United States. It applies its TransCon technology platform to develop therapies in Endocrinology Rare Disease and Oncology, and is publicly traded on Nasdaq (ASND).

biopharmaceutical research and developmentclinical development

Related capabilities

Other processes offered by the shops that list drug innovation using TransCon technology platform.

Browse all capabilities